What’s Hot And What’s Not In China Right Now?

Friday, August 20, 2021 | Sam Quirke
What’s Hot And What’s Not In China Right Now?It’s no secret that many Chinese stocks have been under significant pressure for the past six months. Despite most of the big names rallying through 2020 and continuing to soar to all-time highs in the early months of this year, it’s been nothing short of brutal since. The big driver behind the weakness is the Chinese government, which has launched a vicious regulatory crackdown that is spooking investors both in China, and further afield. 

Their focus has swung from the online gaming industry to the private education sector, to its homegrown big-tech firms. Invesco’s Golden Dragon China ETF (NASDAQ: PGJ), which holds US-listed Chinese stocks, has fallen more than 50% from its February high. Yesterday’s session put paid to any feelings that the sellers might be running out of steam as it sunk another 5% to put it back trading at the same levels it spent much of 2017 at. 

As we head into the final session of the week, let’s take a look at two of the more well-known stocks and see where there might be some buying opportunities starting to open up. For sure there’s volatility right now, but for investors with a long enough time horizon, these stocks and many of their peers are starting to trade at prices that are just too good to ignore.

Alibaba (NYSE: BABA)

Chinese authorities approved plans this week to roll out fresh data privacy laws as well as new unfair competition guidelines for tech companies. Understandably, these moves further dampened the appetite of investors to own Alibaba stock as both will potentially act as major brakes on the growth potential of one of China’s largest companies. Their shares finished the day down close to 7% and at a new 52 week low. 

But as we pondered two weeks ago, is now the time to start thinking about buying Alibaba shares? If you’re a believer in the old adage that the time to buy is when there’s blood on the streets, then it just might be. Their share price has been sliced in half since February and the stock’s RSI is at 20, indicating extremely oversold conditions. 

Their most recent earnings report showed revenue was still growing at 30% year on year, while management is confident enough about their future to be repurchasing shares at a terrific rate. Both of these are attributes of companies that deserve a place in any long term portfolio. And that’s exactly the attitude any investor in China needs. Let’s not forget, this is the company that’s aiming to serve 1 billion customers a year by 2024. 

Weibo (NASDAQ: WB)

Shares of Weibo have been trading sideways since the middle of 2019, which is when they stopped the 70% slide that had started the previous year. As one of the most popular social networks in China, they command a huge market presence and have all the hallmarks of a company that has yet to reach its full potential. 

Their Q2 earnings, released this week, had revenue up 48% on the year and well ahead of what analysts had been expecting. The company also reported more than 500 million monthly active users, confirming the massive reach that Weibo has in the world’s second-biggest economy. 

Because of how much their shares underperformed their Chinese peers in the past two years, they’ve been left relatively unscathed from this current selloff. They’ve fallen 30% from their July levels but are still trading for around the same prices they were at in May, something the folks over at Alibaba would love to be able to say. Compared to its global social network peers, the stock is trading at a deep discount, and there’s a strong argument to be made for starting to scale into a position at these levels. The stock’s RSI is, like Alibaba’s, suggesting extremely oversold conditions, and potential investors have some decent support around the $40 mark to work an entry and stop-loss.
What’s Hot And What’s Not In China Right Now?

Should you invest $1,000 in Alibaba Group right now?

Before you consider Alibaba Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Alibaba Group wasn't on the list.

While Alibaba Group currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The 5 Stocks Here

 


Companies Mentioned in This Article

CompanyMarketRank™Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
Alibaba Group (BABA)2.5$150.68-0.8%N/A18.38Buy$301.78
Weibo (WB)1.6$48.88-1.8%N/A57.51Buy$52.50
Compare These Stocks  Add These Stocks to My Watchlist 

MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.